Table 3.
Clinical characteristics of two clusters in the TCGA-LUSC cohort.
| Cluster 1 (n = 199) | Cluster 2 (n = 195) | Statistical value | p value | |
|---|---|---|---|---|
| Age (median [IQR]) | 68 ([60, 73]) | 69 ([62, 74]) | -1.720 | 0.086 |
| Gender (%) | 1.089 | 0.297 | ||
| Female | 46 (23.1) | 54 (27.7) | ||
| Male | 153 (76.9) | 141 (72.3) | ||
| pT stage (%) | 3.963 | 0.047∗ | ||
| T1-2 | 155 (77.9) | 167 (85.6) | ||
| T3-4 | 44 (22.1) | 28 (14.4) | ||
| pN stage (%) | 25.787 | 0∗∗∗ | ||
| N0 | 102 (51.3) | 148 (75.9) | ||
| N1-N3 | 97 (48.7) | 47 (24.1) | ||
| pM stage | 2.626a | 0.215 | ||
| M0 | 194 (97.5) | 194 (99.5) | ||
| M1 | 5 (2.5) | 1 (0.5) | ||
| pTNM stage (%) | 15.9 | 0∗∗∗ | ||
| I-II | 145 (72.9) | 173 (88.7) | ||
| III-IV | 54 (27.1) | 22 (11.3) |
aFisher exact probability test. ∗p < 0.05 and ∗∗∗p < 0.001.